查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771312

藥物發現平台市場：產業趨勢及全球預測 - 依顯示庫技術類型、分子類型和主要地區

Drug Discovery Platforms Market: Industry Trends and Global Forecasts - Distribution by Type of Display Library Technology, Type of Molecule and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

全球藥物發現平台市場：概覽

今年全球藥物發現平台市場規模為 1.39億美元。在預計預測期內，該市場的年複合成長率將達到 13.4%。

市場區隔與機會分析依下列參數細分：

顯示庫技術類型

  • 噬菌體顯示
  • 酵母顯示
  • 其他

依分子類型

  • 抗體
  • 胜肽
  • 其他

主要地區

  • 北美
  • 歐洲
  • 亞太地區

全球藥物研發平台市場：成長與趨勢

藥物研發一直是個漫長的過程。事實上，一種藥物的商業化上市平均需要10-15年的時間和40-100億美元的投資。藥物研發過程包括標靶選擇和驗證、標靶化合物生成、先導化合物最佳化、方案表徵等多個步驟。在這些步驟中，藥物標靶產生（針對已驗證的生物標靶的潛在候選藥物）是一個極其耗費資源的過程。值得一提的是，針對已驗證的標靶產生一個藥物標靶平均需要約18個月的時間。此外，藥物研發中從藥物標靶生成到先導化合物辨識階段的失敗率約為25%。為了解決這些問題，開發人員正將重點從傳統方法轉向使用新型藥物研發平台。

藥物研發平台市場-IMG1

多年來，人們已經建立了許多方法和途徑來產生可行的治療先導化合物。這些方法包括融合瘤技術、B細胞克隆、基因改造動物技術、體外顯示方法以及包括哺乳動物、酵母和細菌細胞在內的細胞表面顯示技術。在現代醫學研究中，顯示庫已被有效用於開發各種新型療法，並與傳統的藥物篩選方法相比具有許多優點。這些優點包括：能夠進行大規模高通量篩選，提供鑑定可行先導化合物的多樣性，以及降低透過此方法發現的候選藥理化合物引發免疫反應的風險。顯示技術已逐步推動藥物發現過程的重大進步。因此，預計藥物發現平台市場在預測期內將實現強勁成長。

全球藥物發現平台市場：關鍵洞察

本報告分析了全球藥物發現平台市場的現狀，並揭示了潛在的成長機會。報告的主要調查結果包括：

  • 全球不同地區的多家公司聲稱擁有專有的顯示庫技術，並提供合作服務，用於發現各種類型的藥理分子。
  • 噬菌體顯示（約70%）被認為是最成功的顯示技術之一。利害關係人也在探索其他幾種類似的方法，例如基於酵母和哺乳動物細胞的方法。
  • 顯示技術具有多種優勢，包括大規模生產、直接獲取序列以及易於篩選不同的克隆。
  • 顯示庫可用於體外篩選針對固定化抗原的抗體，或分離針對低免疫原性標靶的抗體。
  • 為了產生候選藥物，一些參與者使用多種動物模型進行篩選，這些模型可以在動物免疫系統的控制下進行操控。
  • 從合作活動的增加可以看出，人們對該領域的興趣日益濃厚。事實上，在過去兩年內，包括不同類型顯示庫技術的合作數量達到了最高水準。
藥物發現平台市場-IMG2
  • 現有企業和新創公司都已建立了多種合作夥伴關係，其中大多數是許可協議（約佔45%），許可協議包括可用於研究和治療目的的技術。
  • 與各種類型的體外顯示庫及其實現技術相關的科學文獻出版數量顯著增加，描述其在藥物發現和治療中的應用的方法也顯著增加。
  • 在過去兩年中，關注顯示庫技術及其在藥物發現中的應用的出版物數量（包括研究論文）呈指數級成長。
  • 各種論文都致力於體外顯示技術以及使用大型庫分離大量分子。此外，這些技術主要用於識別有希望用於治療和診斷應用的先導候選藥物。
  • 除噬菌體顯示外，酵母顯示和細胞表面顯示等其他顯示技術也已被研究用於產生各種治療分子。
  • 與顯示庫相關的智慧財產權數量也激增，全球多個組織已提交並獲得授權的大量與這些技術相關的專利（約30,000項專利申請）。
  • 儘管近期提交的專利數量眾多（因此剩餘專利壽命較長），但只有0.21%的專利具有最高的相對估值。
  • 尤其是噬菌體顯示方法已廣泛應用於許多已核准藥物的研發。事實上，市面上最暢銷的生物製劑之一Humira®就是使用相同技術研發的。
  • 預計該市場的年複合成長率將達到13.4%。預計機會將涵蓋各種顯示技術、分子類型和主要地理區域。
藥物發現平台市場-IMG3

參與藥物發現平台市場的公司範例

  • Abzena
  • Creative Biolabs
  • Distributed Bio（Charles River 子公司）
  • ImmunoPrecise Antibodies
  • IONTAS
  • LakePharma
  • Leading Biology
  • Sino Biological
  • XOMA

本報告調查藥物發現平台市場，提供市場概述，以及依顯示庫技術類型、分子類型和地區的趨勢，和參與市場的公司簡介。

目錄

第1章 前言

第2章 執行摘要

第3章 簡介

  • 章節概述
  • 顯示庫技術概述
  • 顯示庫的類型
  • 顯示庫的應用
  • 未來展望

第4章 市場格局：基於庫的顯示技術與服務（噬菌體顯示）

  • 章節概述
  • 顯示庫技術及相關服務（噬菌體顯示）：市場格局
  • 顯示庫技術及相關服務（噬菌體顯示）：主要產業參與者

第5章 市場格局：顯示庫技術及相關服務（其他顯示技術）

  • 章節概述
  • 顯示庫技術及相關服務（其他顯示技術）：市場格局
  • 顯示庫技術及相關服務（其他顯示技術）：主要產業參與者

第6章 公司簡介

  • 章節概述
  • Abzena
  • Creative Biolabs
  • Distributed Bio（Charles River 子公司）
  • ImmunoPrecise Antibodies
  • IONTAS
  • LakePharma
  • Leading Biology
  • Sino Biological
  • XOMA

第7章 案例研究：利用噬菌體發現生物製劑顯示

  • 章節概述
  • 利用噬菌體顯示技術發現的生物製劑
  • 利用噬菌體顯示技術發現的生物製劑：概述
    • HUMIRA®（Adalimumab）
    • TREMFYA®（Guselkumab）
    • TAXYLO®（Lanadelumab）
    • SYNTHA®
    • PORTRAZA™（Necitumumab）
  • 結論

第8章 合作夥伴關係與合作

  • 章節概述
  • 合作模式
  • 顯示庫技術及相關服務：近期合作夥伴關係與合作

第9章 出版品分析

第10章 專利分析

  • 章節概述
  • 研究範圍與研究方法
  • 顯示庫技術：專利分析

第11章 市場規模評估與機會分析

  • 章節概述
  • 關鍵假設與預測研究方法
  • 2035年全球顯示庫技術市場（熱門產品生成服務）
  • 2035年顯示庫技術及相關服務市場：依顯示庫技術類型
  • 2035年顯示庫技術及相關服務市場：依分子類型
  • 2035年顯示庫技術及相關服務市場：依地區

第12章 結論

第13章 高層洞察

第14章 附錄1：表格資料

第15章 附錄2：公司與組織名單

Product Code: RA100273

GLOBAL DRUG DISCOVERY PLATFORMS MARKET: OVERVIEW

As per Roots Analysis, the global drug discovery platforms market valued at USD 139 million in the current year is anticipated to grow at a CAGR of 13.4% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Display Library Technology

  • Phage Display
  • Yeast Display
  • Others

Type of Molecule

  • Antibodies
  • Peptides
  • Others

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific

GLOBAL DRUG DISCOVERY PLATFORMS MARKET: GROWTH AND TRENDS

Drug discovery has always been a time-consuming process. In fact, on average, it takes 10-15 years and investments worth USD 4-10 billion to commercially launch a drug. The process of drug discovery involves various steps including, target selection and validation, hit generation, lead optimization and characterization of protocols. Of these steps, hit (potential drug candidates against validated biological targets) generation is an extremely resource-intensive process. It is worth mentioning that on average approximately 18 months is spent generating hits against a validated target. In addition to this, there is an around 25% chance of failure in the hit generation to lead identification phase of drug discovery. In order to address these concerns, developers are shifting their focus from traditional techniques to the use of novel discovery platforms.

Drug Discovery Platforms Market - IMG1

Over the years, numerous methods and approaches have been established for generating viable therapeutic leads. These include hybridoma technology, B-cell cloning, transgenic animal-based techniques, in vitro display methods and cell surface display techniques involving mammalian, yeast, and bacterial cells. In modern medical research, display libraries have been effectively utilized to generate a range of novel therapeutics and present several advantages over traditional drug screening methods. These benefits include enabling large-scale, high-throughput screening, introducing greater diversity in identifying viable leads, and reducing the risk of immune responses to pharmacological candidates discovered through this approach. Gradually, display technologies have driven significant advancements in the drug discovery process. As a result, we anticipate that the market for drug discovery platforms will experience robust growth over the forecast period.

GLOBAL DRUG DISCOVERY PLATFORMS MARKET: KEY INSIGHTS

The report delves into the current state of global drug discovery platforms market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Several companies, based in different regions of the world, claim to have proprietary display library technologies and offer affiliated services for the discovery of various types of pharmacological molecules.
  • Phage display (~70%) is considered as one of the most successful display technologies; stakeholders are also investigating several other similar approaches, such as those based on yeast and mammalian cells.
  • Display technologies offer several advantages, including large scale production, direct access to sequence and the ease of screening a large diversity of clones.
  • Display libraries can be used for in vitro selection of antibodies on immobilized antigens and isolation of antibodies against poorly immunogenic targets.
  • Some players use multiple animal models for selection that can be manipulated under the control of the animal's immune system to generate drug candidates.
  • The growing interest in this field is evident from the rise in partnership activity; in fact, the maximum number of collaborations involving various types of display library technologies were inked in the past two years.
Drug Discovery Platforms Market - IMG2
  • Both established players, as well as start-ups, have forged multiple partnerships; most of these are licensing agreements (~45%) for the technologies that can be used in research and therapeutic purposes.
  • There has been a notable increase in published scientific literature related to the different types of in vitro display libraries and enabling technologies, and approaches describing their use in the discovery of drugs / therapies.
  • In the past two years, there has been an exponential increase in the number of publications, including research articles focused on display library technologies and their applications in drug discovery.
  • Various articles focus on in-vitro-display technologies and the use of large libraries for the isolation of vast range of molecules. Further, these technologies are primarily aimed at identifying promising lead candidates for use in therapeutic or diagnostic applications.
  • Apart from phage display, other display technologies, such as yeast display and cell surface display are also being investigated for the generation of various therapeutic molecules.
  • The intellectual property associated with display libraries has also witnessed a surge, as numerous patents (~30,000 patent applications) related to these technologies have been filed / granted to several organizations across the globe.
  • Despite the large number of patents that have been filed recently (and hence having a long remaining patent life), only 0.21% of the total patents have the highest relative valuation.
  • Specifically, the phage display approach has been widely used for the discovery of a number of approved drugs; in fact, HUMIRA(R), one of the best-selling biologics in the market, was discovered using the same technology.
  • The market is projected to grow at an annualized rate of ~13.4%; the forecasted opportunity is likely to be distributed across various display technologies, types of molecules, and key geographical regions.
Drug Discovery Platforms Market - IMG3

Example Players in the Drug Discovery Platforms Market

  • Abzena
  • Creative Biolabs
  • Distributed Bio (Subsidiary of Charles River)
  • ImmunoPrecise Antibodies
  • IONTAS
  • LakePharma
  • Leading Biology
  • Sino Biological
  • XOMA

PRIMARY RESEARCH OVERVIEW

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews conducted with the following industry stakeholders:

  • Chief Scientific Officer / Founder and Chief Executive Officer / Founder, Company A
  • Chief Executive Officer / General Manager, Company B
  • President and Chief Executive Officer, Company C
  • General Manager, Company D

GLOBAL DRUG DISCOVERY PLATFORMS MARKET

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global drug discovery platforms market, focusing on key market segments, including [A] type of display library technology, [B] type of molecule and [C] key geographical regions.
  • Market Landscape: A comprehensive evaluation of the display library technologies and affiliated services market, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of company, [E] display library expertise, [F] type of molecules, [G] type and format of antibodies generated, [H] library size / complexity and [I] other services offered.
  • Company Profiles: In-depth profiles of companies offering display library technologies, focusing on [A] company overview, [B] proprietary technology and [C] recent developments and an informed future outlook.
  • Case Study: A detailed discussion of biologics discovered using phage display method along with analysis, based on various parameters, such as [A] first launch year, [B] target gene / antigen, [C] disease indication, [D] target therapeutic area and [E] revenues generated.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] focus area, [D] type of partner, [E] most active players (in terms of the number of partnerships signed) and [F] geographical distribution of partnership activity.
  • Publication Analysis: A comprehensive analysis of close to 2,000 peer-reviewed scientific articles related to research on display libraries, based on [A] year of publication, [B] focus area, [C] type of molecule, [D] popular keywords and [E] key journals.
  • Patent Analysis: An in-depth analysis of patents filed / granted for display library technologies, based on various relevant parameters, such as [A] publication year, [B] geography, [C] CPC symbols, [D] emerging focus areas, [E] type of applicant, [F] leading industry players and [G] patent valuation analysis.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Overview of Display Library Technologies
  • 3.3. Types of Display Libraries
    • 3.3.1. In Vitro Display Technologies
      • 3.3.1.1. Phage Display
        • 3.3.1.1.1. Classification of Phage Display Libraries
        • 3.3.1.1.2. Applications of Phage Display Libraries
      • 3.3.1.2. Ribosomal Display Library
      • 3.3.1.3. mRNA Display Library
      • 3.3.1.4. cDNA Display Library
    • 3.3.2. Cell Surface Display Technologies
      • 3.3.2.1. Bacterial Display Library
      • 3.3.2.2. Yeast Display Library
      • 3.3.2.3. Mammalian Cell-based Display Libraries
  • 3.4. Applications of Display Libraries
  • 3.5. Future Perspectives

4. MARKET LANDSCAPE: LIBRARY-BASED DISPLAY TECHNOLOGIES AND SERVICES (FOCUS ON PHAGE DISPLAY)

  • 4.1. Chapter Overview
  • 4.2. Display Library Technologies and Affiliated Services (Focus on Phage Display): Overall Market Landscape
    • 4.2.1. Analysis by Type of Molecule Discovered
    • 4.2.2. Analysis by Type of Antibodies Generated
    • 4.2.3. Analysis by Type of Library
    • 4.2.4. Analysis by Library Size / Complexity
    • 4.2.5. Analysis by Source Organism
    • 4.2.6. Analysis by Types of Services Offered
  • 4.3. Display Library Technologies and Affiliated Services (Focus on Phage Display): Key Industry Players
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Type of Company
    • 4.3.4. Analysis by Location of Headquarters

5. MARKET LANDSCAPE: DISPLAY LIBRARY TECHNOLOGIES AND AFFILIATED SERVICES (FOCUS ON OTHER DISPLAY TECHNOLOGIES)

  • 5.1. Chapter Overview
  • 5.2. Display Library Technologies and Affiliated Services (Focus on Other Display Technologies): Overall Market Landscape
    • 5.2.1. Analysis by Type of Technology
    • 5.2.2. Analysis by Type of Molecule Discovered
    • 5.2.3. Analysis by Type of Antibodies Generated
    • 5.2.4. Analysis by Type of Library
    • 5.2.5. Analysis by Library Size / Complexity
    • 5.2.6. Analysis by Source Organism
    • 5.2.7. Analysis by Types of Services Offered
  • 5.3. Display Library Technologies and Affiliated Services (Focus on Other Display Technologies): Key Industry Players
    • 5.3.1. Analysis by Year of Establishment
    • 5.3.2. Analysis by Company Size
    • 5.3.3. Analysis by Type of Company
    • 5.3.4. Analysis by Location of Headquarters

6. COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. Abzena
    • 6.2.1. Company Overview
    • 6.2.2. Technology Portfolio
    • 6.2.3. Recent Developments and Future Outlook
  • 6.3. Creative Biolabs
    • 6.3.1. Company overview
    • 6.3.2. Technology Portfolio
    • 6.3.3. Service Portfolio
    • 6.3.4. Recent Developments and Future Outlook
  • 6.4. Distributed Bio (Subsidiary of Charles River)
    • 6.4.1. Company Overview
    • 6.4.2. Technology Portfolio
      • 6.4.2.1. Recent Developments and Future Outlook
  • 6.5. ImmunoPrecise Antibodies
    • 6.5.1. Company Overview
    • 6.5.2. Technology Portfolio
    • 6.5.3. Service Portfolio
    • 6.5.4. Recent Developments and Future Outlook
  • 6.6. IONTAS
    • 6.6.1. Company Overview
    • 6.6.2. Technology Portfolio
    • 6.6.3. Service Portfolio
    • 6.6.4. Recent Developments and Future Outlook
  • 6.7. LakePharma
    • 6.7.1. Company Overview
    • 6.7.2. Technology Portfolio
    • 6.7.3. Service Portfolio
    • 6.7.4. Recent Developments and Future Outlook
  • 6.8. Leading Biology
    • 6.8.1. Company overview
    • 6.8.2. Technology Portfolio
    • 6.8.3. Service Portfolio
    • 6.8.4. Recent Developments and Future Outlook
  • 6.9. Sino Biological
    • 6.9.1. Company Overview
    • 6.9.2. Technology Portfolio
    • 6.9.3. Service Portfolio
    • 6.9.4. Recent Developments and Future Outlook
  • 6.10. XOMA
    • 6.10.1. Company Overview
    • 6.10.2. Technology Portfolio
    • 6.10.3. Recent Developments and Future Outlook

7. CASE STUDY: BIOLOGICS DISCOVERED USING PHAGE DISPLAY METHOD

  • 7.1. Chapter Overview
  • 7.2. Biologics Discovered Using the Phage Display Method
    • 7.2.1. Analysis by Year of Launch
    • 7.2.2. Analysis by Target Antigen / Gene
    • 7.2.3. Analysis by Target Disease Indication and Therapeutic Area
    • 7.2.4. Analysis by Revenues Generated (2020)
  • 7.3. Biologics Discovered Using Phage Display Method: Brief Profiles
    • 7.3.1. Humira(R) (Adalimumab)
      • 7.3.1.1. Drug Overview
      • 7.3.1.2. Discovery Process and Method
    • 7.3.2. Tremfya(R) (Guselkumab)
      • 7.3.2.1. Drug Overview
      • 7.3.2.2. Discovery Process and Method
    • 7.3.3. Takhzyro(R) (Lanadelumab)
      • 7.3.3.1. Drug Overview
      • 7.3.3.2. Discovery Process and Method
    • 7.3.4. Xyntha(R)
      • 7.3.4.1. Drug Overview
      • 7.3.4.2. Discovery Process and Method
    • 7.3.5. Portrazza(TM) (Necitumumab)
      • 7.3.5.1. Drug Overview
      • 7.3.5.2. Discovery Process and Method
  • 7.4. Concluding Remarks

8. PARTNERSHIPS AND COLLABORATIONS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Display Library Technologies and Affiliated Services: Recent Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Focus of Partnership (Type of Molecule)
    • 8.3.4. Analysis by Focus of Partnership (Target Therapeutic Area)
    • 8.3.5. Analysis by Type of Partner
    • 8.3.6. Most Active Players: Analysis by Number of Partnerships
    • 8.3.7. Analysis by Geography
      • 8.3.7.1. Intercontinental and Intracontinental Agreements

9. PUBLICATION ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Analysis by Year of Publication
  • 9.4. Analysis by Focus Area (Type of Technology)
  • 9.5. Analysis by Focus Area (Type of Molecule)
  • 9.6. Word Cloud: Analysis of Study Titles
  • 9.7. Key Journals: Analysis by Number of Publications

10. PATENT ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Scope and Methodology
  • 10.3. Display Library Technologies: Patent Analysis
    • 10.3.1. Analysis by Publication Year
    • 10.3.2. Analysis by Geography
    • 10.3.3. Analysis by CPC Symbols
    • 10.3.4. Emerging Focus Areas (Word Cloud)
    • 10.3.5. Analysis by Type of Applicant
    • 10.3.6. Leading Players: Analysis by Number of Patents
    • 10.3.7. Leading Players: International Patents
    • 10.3.8. Display Library Technologies: Patent Valuation Analysis

11. MARKET SIZING AND OPPORTUNITY ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Key assumptions and Forecast Methodology
  • 11.3. Global Display Library Technologies Market (Focus on Hit Generation Services), Till 2035
  • 11.4. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Type of Display Library Technology
  • 11.5. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Type of Molecule
  • 11.6. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Geography
    • 11.6.1. Display Library Technologies and Affiliated Services Market Opportunity in North America Across Key Market Segments, Till 2035
      • 11.6.1.1. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Distribution by Type of Technology
        • 11.6.1.1.1 Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Phage Display Technology
        • 11.6.1.1.2. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Yeast Display Technology
        • 11.6.1.1.3. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Other Display Technologies
      • 11.6.1.2. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Distribution by Type of Molecule
        • 11.6.1.2.1. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Antibodies
        • 11.6.1.2.2. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Peptides
        • 11.6.1.2.3. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Other Molecules
    • 11.6.2. Display Library Technologies and Affiliated Services Market Opportunity in Europe Across Key Market Segments, Till 2035
      • 11.6.2.1. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Distribution by Type of Technology
        • 11.6.2.1.1 Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Phage Display Technology
        • 11.6.2.1.2. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Yeast Display Technology
        • 11.6.2.1.3. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Other Display Technologies
      • 11.6.2.2. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Distribution by Type of Molecule
        • 11.6.2.2.1. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Antibodies
        • 11.6.2.2.2. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Peptides
        • 11.6.2.2.3. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Other Molecules
    • 11.6.3. Display Library Technologies and Affiliated Services Market Opportunity in Asia-Pacific Across Key Market Segments, Till 2035
      • 11.6.3.1. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Distribution by Type of Technology
        • 11.6.3.1.1 Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Phage Display Technology
        • 11.6.3.1.2. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Yeast Display Technology
        • 11.6.3.1.3. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Other Display Technologies
      • 11.6.3.2. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Distribution by Type of Molecule
        • 11.6.3.2.1. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Antibodies
        • 11.6.3.2.2. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Peptides
        • 11.6.3.2.3. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Other Molecules

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

  • 13.1. Chapter Overview
  • 13.2. Company A
    • 13.2.1. Company Snapshot
    • 13.2.2. Interview Transcript: CSO / Founder and CEO / Founder
  • 13.3. Company B
    • 13.3.1. Company Snapshot
    • 13.3.2. Interview Transcript: CEO / General Manager
  • 13.4. Company C
    • 13.4.1. Company Snapshot
    • 13.4.2. Interview Transcript: President and CEO
  • 13.5. Company D
    • 13.5.1. Company Snapshot
    • 13.5.2. Interview Transcript: General Manager

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Figure 3.1. Popular Display Library Technologies
  • Figure 3.2. Structure of a Bacteriophage
  • Figure 3.3. Phage Display Technique: Basic Steps
  • Figure 3.4. Construction of mRNA Display Technology
  • Figure 3.5. Construction of Bacterial Display Library
  • Figure 4.1. Phage Display Library Technologies and Affiliated Services: Type of Molecule Discovered
  • Figure 4.2. Phage Display Library Technologies and Affiliated Services: Distribution by Type of Antibodies Generated
  • Figure 4.3. Phage Display Library Technologies and Affiliated Services: Distribution by Type of Library
  • Figure 4.4. Phage Display Library Technologies and Affiliated Services: Distribution by Library Size / Complexity
  • Figure 4.5. Phage Display Library Technologies and Affiliated Services: Distribution by Source Organism
  • Figure 4.6. Phage Display Library Technologies and Affiliated Services: Distribution by Types of Services Offered
  • Figure 4.7. Phage Display Library Technologies and Affiliated Service Providers: Distribution by Year of Establishment
  • Figure 4.8. Phage Display Library Technologies and Affiliated Service Providers: Distribution by Company Size
  • Figure 4.9. Phage Display Library Technologies and Affiliated Service Providers: Distribution by Type of Company
  • Figure 4.10. Phage Display Library Technologies and Affiliated Service Providers: Distribution by Location of Headquarters
  • Figure 5.1. Other Display Library Technologies and Affiliated Services: Distribution by Type of Molecule Discovered
  • Figure 5.2. Other Display Library Technologies and Affiliated Services: Distribution by Type of Antibodies Generated
  • Figure 5.3. Other Display Library Technologies and Affiliated Services: Distribution by Type of Library
  • Figure 5.4. Other Display Library Technologies and Affiliated Services: Distribution by Library Size / Complexity
  • Figure 5.5. Other Display Library Technologies and Affiliated Services: Distribution by Source Organism
  • Figure 5.6. Other Display Library Technologies and Affiliated Services: Distribution by Types of Services Offered
  • Figure 5.7. Other Display Library Technologies and Affiliated Service Providers: Distribution by Year of Establishment
  • Figure 5.8. Other Display Library Technologies and Affiliated Service Providers: Distribution by Company Size
  • Figure 5.9. Other Display Library Technologies and Affiliated Service Providers: Distribution by Type of Company
  • Figure 5.10. Other Display Library Technologies and Affiliated Service Providers: Distribution by Location of Headquarters
  • Figure 6.1. Creative Biolabs: Service Portfolio
  • Figure 6.2. ImmunoPrecise Antibodies: Service Portfolio
  • Figure 6.3. IONTAS: Service Portfolio
  • Figure 6.4. LakePharma: Service Portfolio
  • Figure 6.5. Leading Biology: Service Portfolio
  • Figure 6.6. Leading Biology: Premade Phage Display Antibody Libraries
  • Figure 6.7. Sino Biological: Service Portfolio
  • Figure 7.1. Biologics Discovered Using Phage Display Method: First Launch Timeline
  • Figure 7.2. Biologics Discovered Using Phage Display Method: Word Cloud Representation of Target Antigen / Gene
  • Figure 7.3. Biologics Discovered Using Phage Display Method: Distribution by Target Disease Indications and Therapeutic Area
  • Figure 7.4. Biologics Discovered Using Phage Display Method: Logo Landscape Highlighting Revenues Generated in 2020
  • Figure 8.1. Partnerships and Collaborations: Distribution by Year of Partnership
  • Figure 8.2. Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3. Partnerships and Collaborations: Distribution by Focus Area (Type of Molecule)
  • Figure 8.4. Partnerships and Collaborations: Distribution by Focus Area (Target Therapeutic Area)
  • Figure 8.5. Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 8.6. Most Active Players: Distribution by Number of Partnerships
  • Figure 8.7. Partnerships and Collaborations: Distribution by Geography
  • Figure 8.8. Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Agreements
  • Figure 9.1. Publication Analysis: Cumulative Year-wise Trend, Since 2017
  • Figure 9.2. Publication Analysis: Distribution by Focus Area
  • Figure 9.3. Publication Analysis: Distribution by Type of Molecule
  • Figure 9.4. Publication Analysis: Word Cloud of Study Titles
  • Figure 9.5. Key Journals: Distribution by Number of Publications
  • Figure 10.1. Patent Analysis: Distribution by Type of Patent
  • Figure 10.2. Patent Analysis: Cumulative Distribution by Publication Year, Since 2017
  • Figure 10.3. Patent Analysis: Distribution by Type of Patent and Publication Year
  • Figure 10.4. Patent Analysis: Distribution by Geography
  • Figure 10.5. Patent Analysis: Distribution by Jurisdiction
  • Figure 10.6. Patent Analysis: Distribution by CPC Symbols
  • Figure 10.7. Patent Analysis: Emerging Focus Areas
  • Figure 10.8. Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
  • Figure 10.9. Leading Industry Players: Distribution by Number of Patents
  • Figure 10.10. Leading Players: Distribution by International Patents
  • Figure 10.11. Patent Analysis: Distribution of Patents by Age
  • Figure 10.12. Patent Analysis: Distribution of Patents by Geography, Since 2017
  • Figure 10.13. Display Library Technologies: Patent Valuation
  • Figure 11.1. Global Display Library Technologies and Affiliated Services Market (Focus on Hit Generation Services), Till 2035 (USD Million)
  • Figure 11.2. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Type of Display Library Technology (USD Million)
  • Figure 11.3. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Type of Molecule (USD Million)
  • Figure 11.4. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Geography (USD Million)
  • Figure 11.5. Display Library Technologies and Affiliated Services Market in North America, Till 2035 (USD Million)
  • Figure 11.6. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Phage Display Technology (USD Million)
  • Figure 11.7. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Yeast Display Technology (USD Million)
  • Figure 11.8. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Other Display Technologies (USD Million)
  • Figure 11.9. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Antibodies (USD Million)
  • Figure 11.10. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Peptides (USD Million)
  • Figure 11.11. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Other Molecules (USD Million)
  • Figure 11.12. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Phage Display Technology (USD Million)
  • Figure 11.13. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Yeast Display Technology (USD Million)
  • Figure 11.14. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Other Display Technologies (USD Million)
  • Figure 11.15. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Antibodies (USD Million)
  • Figure 11.16. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Peptides (USD Million)
  • Figure 11.17. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Other Molecules (USD Million)
  • Figure 11.18. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Phage Display Technology (USD Million)
  • Figure 11.19. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Yeast Display Technology (USD Million)
  • Figure 11.20. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Other Display Technologies (USD Million)
  • Figure 11.21. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Antibodies (USD Million)
  • Figure 11.22. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Peptides (USD Million)
  • Figure 11.23. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Other Molecules (USD Million)

List of Figures

  • Table 4.1. Display Library Technologies and Affiliated Services Market Landscape (Focus on Phage Display): Information on Developers, Type of Molecule Generated and Types of Antibodies Generated
  • Table 4.2. Display Library Technologies and Affiliated Services Market Landscape (Focus on Phage Display): Information on Type of Library and Library Size / Complexity
  • Table 4.3. Display Library Technologies and Affiliated Services Market Landscape (Focus on Phage Display): Information on Animal Model Use
  • Table 4.4. Display Library Technologies and Affiliated Services Market Landscape (Focus on Phage Display): Information on Types of Services Offered
  • Table 4.5. Display Library Technologies and Affiliated Services Market Landscape (Focus on Phage Display): Companies Offering Drug Discovery Platform(s)
  • Table 4.6. Display Library Technologies and Affiliated Services Market Landscape (Focus on Phage Display): List of Companies
  • Table 5.1. Display Library Technologies and Affiliated Services Market Landscape (Focus on Other Display Technologies): Information on Developer, Type of Molecule Generated and Type of Antibodies Generated
  • Table 5.2. Display Library Technologies and Affiliated Services Market Landscape (Focus on Other Display Technologies): Information on Type of Library and Library Size / Complexity
  • Table 5.3. Display Library Technologies and Affiliated Services Market Landscape (Focus on Other Display Technologies): Information on Animal Model Used
  • Table 5.4. Display Library Technologies and Affiliated Services Market Landscape (Focus on Other Display Technologies): Information on Types of Services Offered
  • Table 5.5. Display Library Technologies and Affiliated Services Market Landscape (Focus on Other Display Technologies): Companies Offering Drug Discovery Platform(s)
  • Table 4.6. Display Library Technologies and Affiliated Services Market Landscape (Focus on Other Display Technologies): List of Companies
  • Table 6.1. Display Library Technologies and Affiliated Services: List of Companies Profiled
  • Table 6.2. Abzena: Company Snapshot
  • Table 6.3. Abzena: Recent Developments and Future Outlook
  • Table 6.4. Creative Biolabs: Company Snapshot
  • Table 6.5. Creative Biolabs: Recent Developments and Future Outlook
  • Table 6.6. Distributed Bio: Company Snapshot
  • Table 6.6. Distributed Bio: Recent Developments and Future Outlook
  • Table 6.7. ImmunoPrecise Antibodies: Company Snapshot
  • Table 6.8. ImmunoPrecise Antibodies: Recent Developments and Future Outlook
  • Table 6.9. IONTAS: Company Snapshot
  • Table 6.10. IONTAS: Recent Developments and Future Outlook
  • Table 6.11. LakePharma: Company Snapshot
  • Table 6.12. LakePharma: Recent Developments and Future Outlook
  • Table 6.13. Leading Biology: Company Snapshot
  • Table 6.14. Sino Biological: Company Snapshot
  • Table 6.16. XOMA: Company Snapshot
  • Table 6.17. XOMA: Recent Developments and Future Outlook
  • Table 7.1. List of Approved Biologics Discovered Using Phage Display Method: Information on Launch Year, Target, Indication and Therapeutic Area
  • Table 7.2. List of Clinical Stage Biologics Discovered Using Phage Display Library Method
  • Table 8.1. Partnerships and Collaborations: Information on Year and Type, Since 2017
  • Table 8.2. Partnerships and Collaborations: Information on Focus Area
  • Table 8.3. Partnerships and Collaborations: Information on Geography
  • Table 10.1. Display Library Technologies: Prominent CPC Codes
  • Table 10.2. Display Library Technologies: Most Popular CPC Symbols
  • Table 10.3. Display Library Technologies: List of Top CPC Symbols
  • Table 10.4. Patent Valuation Analysis: Categorization based on Weighted Valuation Scores
  • Table 10.5. Patent Analysis: List of Relatively High Value Patents
  • Table 14.1. Phage Display Library Technologies and Affiliated Services: Type of Molecule Discovered
  • Table 14.2. Phage Display Library Technologies and Affiliated Services: Distribution by Type of Antibodies Generated
  • Table 14.3. Phage Display Library Technologies and Affiliated Services: Distribution by Type of Library
  • Table 14.4. Phage Display Library Technologies and Affiliated Services: Distribution by Library Size / Complexity
  • Table 14.5. Phage Display Library Technologies and Affiliated Services: Distribution by Animal Model Used
  • Table 14.6. Phage Display Library Technologies and Affiliated Services: Distribution by Types of Services Offered
  • Table 14.7. Phage Display Library Technologies and Affiliated Service Providers: Distribution by Year of Establishment
  • Table 14.8. Phage Display Library Technologies and Affiliated Service Providers: Distribution by Company Size
  • Table 14.9. Phage Display Library Technologies and Affiliated Service Providers: Distribution by Type of Company
  • Table 14.10. Phage Display Library Technologies and Affiliated Service Providers: Distribution by Location of Headquarters
  • Table 14.11. Other Display Library Technologies and Affiliated Services: Distribution by Type of Molecules Generated
  • Table 14.12. Other Display Library Technologies and Affiliated Services: Distribution by Type of Antibodies Generated
  • Table 14.14. Other Display Library Technologies and Affiliated Services: Distribution by Type of Library
  • Table 14.14. Other Display Library Technologies and Affiliated Services: Distribution by Library Size / Complexity
  • Table 14.15. Other Display Library Technologies and Affiliated Services: Distribution by Animal Model Used
  • Table 14.16. Other Display Library Technologies and Affiliated Services: Distribution by Types of Services Offered
  • Table 14.17. Other Display Library Technologies and Affiliated Service Providers: Distribution by Year of Establishment
  • Table 14.18. Other Display Library Technologies and Affiliated Service Providers: Distribution by Company Size
  • Table 14.19. Other Display Library Technologies and Affiliated Service Providers: Distribution by Type of Company
  • Table 14.20. Other Display Library Technologies and Affiliated Service Providers: Distribution by Location of Headquarters
  • Table 14.21. Biologics Discovered Using Phage Display Method: First Launch Year Timeline
  • Table 14.22. Biologics Discovered Using Phage Display Method: Distribution by Target Disease Indications and Therapeutic Area
  • Table 14.23. Partnerships and Collaborations: Distribution by Year of Partnership
  • Table 14.24. Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 14.25. Partnerships and Collaborations: Distribution by Focus Area (Type of Molecule)
  • Table 14.26. Partnerships and Collaborations: Distribution by Focus Area (Target Therapeutic Area)
  • Table 14.27. Partnerships and Collaborations: Distribution by Type of Partner
  • Table 14.28. Most Active Players: Distribution by Number of Partnerships
  • Table 14.29. Partnerships and Collaborations: Distribution by Geography
  • Table 14.30. Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Agreements
  • Table 14.31. Publication Analysis: Cumulative Year-wise Trend, Since 2017
  • Table 14.32. Publication Analysis: Distribution by Focus Area
  • Table 14.33. Publication Analysis: Distribution by Type of Molecule
  • Table 14.34. Key Journals: Distribution by Number of Publications
  • Table 14.35. Patent Analysis: Distribution by Type of Patent
  • Table 14.36. Patent Analysis: Cumulative Distribution by Publication Year, Since 2017
  • Table 14.37. Patent Analysis: Distribution by Type of Patent and Publication Year
  • Table 14.38. Patent Analysis: Distribution by Geography
  • Table 14.39. Patent Analysis: Distribution by Jurisdiction
  • Table 14.40. Patent Analysis: Distribution by CPC Symbols
  • Table 14.41. Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
  • Table 14.42. Leading Industry Players: Distribution by Number of Patents
  • Table 14.43. Leading Players: Distribution by International Patents
  • Table 14.44. Patent Analysis: Distribution of Patents by Age
  • Table 14.45. Patent Analysis: Distribution of Patents by Geography, Since 2017
  • Table 14.46. Display Library Technologies: Patent Valuation
  • Table 14.47. Global Display Library Technologies and Affiliated Services Market (Focus on Hit Generation Services), Till 2035 (USD Million)
  • Table 14.48. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Type of Display Library Technology (USD Million)
  • Table 14.49. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Type of Molecule (USD Million)
  • Table 14.50. Display Library Technologies and Affiliated Services Market, Till 2035: Distribution by Geography (USD Million)
  • Table 14.51. Display Library Technologies and Affiliated Services Market in North America, Till 2035 (USD Million)
  • Table 14.52. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Phage Display Technology (USD Million)
  • Table 14.53. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Yeast Display Technology (USD Million)
  • Table 14.54. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Other Display Technologies (USD Million)
  • Table 14.55. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Antibodies (USD Million)
  • Table 14.56. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Peptides (USD Million)
  • Table 14.57. Display Library Technologies and Affiliated Services Market in North America, Till 2035: Share of Other Molecules (USD Million)
  • Table 14.58. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Phage Display Technology (USD Million)
  • Table 14.59. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Yeast Display Technology (USD Million)
  • Table 14.60. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Other Display Technologies (USD Million)
  • Table 14.61. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Antibodies (USD Million)
  • Table 14.62. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Peptides (USD Million)
  • Table 14.63. Display Library Technologies and Affiliated Services Market in Europe, Till 2035: Share of Other Molecules (USD Million)
  • Table 14.64. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Phage Display Technology (USD Million)
  • Table 14.65. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Yeast Display Technology (USD Million)
  • Table 14.66. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Other Display Technologies (USD Million)
  • Table 14.67. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Antibodies (USD Million)
  • Table 14.68. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Peptides (USD Million)
  • Table 14.69. Display Library Technologies and Affiliated Services Market in Asia-Pacific, Till 2035: Share of Other Molecules (USD Million)